Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 12

Apelin and chemerin as promising adipokines in children with type 1 diabetes mellitus

Authors Elsehmawy AAEW, El-Toukhy SE, Seliem NMA, Moustafa RS, Mohammed DS

Received 30 September 2018

Accepted for publication 29 January 2019

Published 22 March 2019 Volume 2019:12 Pages 383—389


Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Ms Justinn Cochran

Peer reviewer comments 3

Editor who approved publication: Dr Konstantinos Tziomalos

Asmaa Abd El Wakeel Elsehmawy,1 Safinaz Ebrahim El-Toukhy,2 Nora Mohamed Ahmed Seliem,3 Rehab Selim Moustafa,4 Doaa Sayed Mohammed5

1Department of Pediatrics, Faculty of Medicine, Al-Azhar University, Cairo, Egypt; 2Department of Medical Biochemistry, National Research Center, Cairo, Egypt; 3Biochemistry Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt; 4Child Health Department, National Research Center, Cairo, Egypt; 5Endocrine Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt

Background: Type 1 diabetes mellitus (T1DM) is one of the most common chronic diseases in children that may be due to micro or macrovascular complications. Diabetic renal disease or nephropathy is a common complication of DM, clinically silent and the only detectable abnormality due to the presence of microalbuminuria.
Subjects and methods: This study was a case–control study. Participants were classified into two groups. The first group included 40 children with T1DM and the second group included 30 matched healthy controls. Serum apelin (APLN), chemerin, cholesterol, and triglycerides (TG) levels were measured for each case. Also, albumin/creatinine ratio was analyzed in random urine sample.
Results: Comparison between T1DM patients and controls revealed that serum apelin, chemerin, cholesterol, TG levels, and albuminuria were significantly increased in cases compared to their controls. Significant positive correlations were found between HbA1c% and albuminuria for APLN and chemerin in the diabetic group. Whereas significant negative correlations were found between apelin and glomerular filtration rate (GFR).
Conclusion: Increased levels of serum apelin and chemerin in T1DM patients may be considered as promising adipokines for the development of diabetic complication.

Keywords: apelin, chemerin, children, diabetes mellitus

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]